Trial Profile
The study of ANagliptin effects on Glucagon LEvels of type 2 DM patients using insulin / ANGLE study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Apr 2018
Price :
$35
*
At a glance
- Drugs Anagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms ANGLE
- 16 Apr 2018 Status changed from active, no longer recruiting to completed.
- 04 Aug 2017 Status changed from recruiting to active, no longer recruiting.
- 09 Feb 2017 Status changed from not yet recruiting to recruiting.